Katherine Beaverson
Senior Director and Patient Advocacy Lead, Rare Disease Research Unit, Pfizer (Festival Underwriter)
Katherine Beaverson is a senior director and patient advocacy lead in the Rare Disease Research Unit (RDRU) at Pfizer, where she leads the strategic planning and implementation of collaborations with patient advocacy groups in support of Pfizer’s RDRU pipeline portfolio. Previously, she was the senior associate director of patient advocacy and professional relations at Boehringer Ingelheim and director of patient advocacy for Amicus Therapeutics. Professionally trained as a genetic counselor, Beaverson also spent ten years in academic medicine, as a genetic counselor at both New York Presbyterian Hospital/Weill Cornell Medical Center and at Memorial Sloan-Kettering Cancer Center.